Works matching DE "DOCETAXEL"

Results: 3408

Nimotuzumab combined with docetaxel and cisplatin as first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma: a multicenter, phase 2 trial.

Published in:

BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-04103-0

By:

Zou, Qihua;
Cao, Yi;
Lai, Yulin;
Fang, Yu;
Zhang, Yuchen;
Liu, Panpan;
Lu, Lixia;
Wu, Hao;
Huang, Tianying;
Su, Ning;
Li, Zhihua;
Wang, Xicheng;
Tian, Xiaopeng;
Li, Lirong;
Liu, Yingxian;
Cai, Qingqing;
Xia, Yi

Publication type:

Article

Docetaxel-induced palmoplantar erythrodysesthesia syndrome and long-lasting multiple nail changes.

Published in:

Indian Journal of Pharmacology, 2014, v. 46, n. 2, p. 225, doi. 10.4103/0253-7613.129326

By:

Akoglu, Gulsen

Publication type:

Article

Docetaxel-induced photolichenoid eruption.

Published in:

2009

By:

Vasudevan, Biju;
Sawhney, M. P. S.;
Sharma, Nitu

Publication type:

Case Study

A transfer learning approach via procrustes analysis and mean shift for cancer drug sensitivity prediction.

Published in:

Journal of Bioinformatics & Computational Biology, 2018, v. 16, n. 3, p. N.PAG, doi. 10.1142/S0219720018400140

By:

Turki, Turki;
Wei, Zhi;
Wang, Jason T. L.

Publication type:

Article

Dual-Functional PEI-Poly(γ-Cholesterol- l-Glutamate) Copolymer for Drug/Gene Co-delivery.

Published in:

Macromolecular Chemistry & Physics, 2014, v. 215, n. 2, p. 163, doi. 10.1002/macp.201300551

By:

Zhang, Jinkun;
Fang, Dailong;
Ma, Qing;
He, Zhiyao;
Ren, Ke;
Zhou, Rui;
Zeng, Shi;
Li, Bo;
He, Lili;
He, Gu;
Song, Xiangrong

Publication type:

Article

Radiolabeled Polymeric Nanoconstructs Loaded with Docetaxel and Curcumin for Cancer Combinatorial Therapy and Nuclear Imaging.

Published in:

Advanced Functional Materials, 2015, v. 25, n. 22, p. 3371, doi. 10.1002/adfm.201500627

By:

Stigliano, Cinzia;
Key, Jaehong;
Ramirez, Maricela;
Aryal, Santosh;
Decuzzi, Paolo

Publication type:

Article

Abstracts from 38th Congress of the Société Internationale d’Urologie Seoul Dragon City, October 4-7, 2018.

Published in:: 2018
Publication type:: Abstract

Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort.

Published in:

World Journal of Urology, 2015, v. 33, n. 6, p. 833, doi. 10.1007/s00345-014-1375-5

By:

Höfner, Thomas;
Vallet, Sonia;
Hadaschik, Boris;
Pahernik, Sascha;
Duensing, Stefan;
Hohenfellner, Markus;
Jäger, Dirk;
Grüllich, Carsten

Publication type:

Article

Is there an anti-androgen withdrawal syndrome for enzalutamide?

Published in:

World Journal of Urology, 2014, v. 32, n. 5, p. 1171, doi. 10.1007/s00345-014-1288-3

By:

Klot, Christoph;
Kramer, Mario;
Böker, Alena;
Herrmann, Thomas;
Peters, Inga;
Kuczyk, Markus;
Ligges, Uwe;
Gschwend, Jürgen;
Retz, Margitta;
Schmid, Sebastian;
Stenzl, Arnulf;
Schwentner, Christian;
Todenhöfer, Tilmann;
Stöckle, Michael;
Ohlmann, Carsten-Henning;
Azone, Ines;
Mager, René;
Bartsch, Georg;
Haferkamp, Axel;
Heidenreich, Axel

Publication type:

Article

Novel options for the treatment of castration-resistant prostate cancer.

Published in:

World Journal of Urology, 2012, v. 30, n. 4, p. 495, doi. 10.1007/s00345-011-0796-7

By:

Ohlmann, Carsten-H.;
Merseburger, Axel;
Suttmann, Henrik;
Schilling, David;
Trojan, Lutz;
Kempkensteffen, Carsten;
Corvin, Stefan;
Mathers, Michael;
Bastian, Patrick

Publication type:

Article

Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer.

Published in:

World Journal of Urology, 2010, v. 28, n. 3, p. 391, doi. 10.1007/s00345-010-0527-5

By:

Reuter, Christoph W. M.;
Morgan, Michael A.;
Ivanyi, Philipp;
Fenner, Martin;
Ganser, Arnold;
Grünwald, Viktor

Publication type:

Article

The novel use of intravesical docetaxel for the treatment of non-muscle invasive bladder cancer refractory to BCG therapy: a single institution experience.

Published in:

World Journal of Urology, 2009, v. 27, n. 3, p. 331, doi. 10.1007/s00345-009-0377-1

By:

Barlow, LaMont J.;
McKiernan, James M.;
Benson, Mitchell C.

Publication type:

Article

Docetaxel and bortezomib downregulate Bcl-2 and sensitize PC-3- Bcl-2 expressing prostate cancer cells to irradiation.

Published in:

World Journal of Urology, 2008, v. 26, n. 5, p. 509, doi. 10.1007/s00345-008-0289-5

By:

Wengang Cao;
Shiverick, Kathleen;
Namiki, Kazunori;
Sakai, Yoshihisa;
Porvasnik, Stacy;
Urbanek, Cydney;
Rosser, Charles

Publication type:

Article

Rationale for the development and current status of calcitriol in androgen-independent prostate cancer.

Published in:

World Journal of Urology, 2005, v. 23, n. 1, p. 28, doi. 10.1007/s00345-004-0476-y

By:

Beer, Tomasz;
Myrthue, Anne;
Eilers, Kristine

Publication type:

Article

Chemotherapy for androgen-independent prostate cancer.

Published in:

World Journal of Urology, 2005, v. 23, n. 1, p. 10, doi. 10.1007/s00345-004-0482-0

By:

Petrylak, Daniel

Publication type:

Article

Targeting Bcl-2 with oblimersen for patients with hormone refractory prostate cancer.

Published in:

World Journal of Urology, 2005, v. 23, n. 1, p. 33, doi. 10.1007/s00345-004-0477-x

By:

Chi, Kim

Publication type:

Article

Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 3, p. 635, doi. 10.1007/s00280-011-1742-5

By:

Lee, Eun;
Rha, Sun;
Lee, Jeeyun;
Park, Kyong;
Ahn, Jin-Hee

Publication type:

Article

Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 351, doi. 10.1007/s00280-011-1694-9

By:

Boukovinas, Ioannis;
Androulakis, Nikolaos;
Kentepozidis, Nikolaos;
Polyzos, Aris;
Papakotoulas, Pavlos;
Ziras, Nikolaos;
Kotsakis, Athanasios;
Vardakis, Nikolaos;
Karampeazis, Athanasios;
Markos, Vassilis;
Kostakopoulos, Athanasios;
Constantinides, Constantine;
Samonis, George;
Mavroudis, Dimitris;
Georgoulias, Vassilis

Publication type:

Article

A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 369, doi. 10.1007/s00280-011-1710-0

By:

Grossi, Francesco;
Marinis, Filippo;
Gebbia, Vittorio;
Riccardi, Ferdinando;
Caffo, Orazio;
Gamucci, Teresa;
Ferraù, Francesco;
Nardi, Mario;
Moscetti, Luca;
Boni, Luca;
Dondi, Davide;
Galligioni, Enzo

Publication type:

Article

A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601).

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 407, doi. 10.1007/s00280-011-1701-1

By:

Koizumi, Wasaburo;
Nakayama, Norisuke;
Tanabe, Satoshi;
Sasaki, Tohru;
Higuchi, Katsuhiko;
Nishimura, Ken;
Takagi, Seiichi;
Azuma, Mizutomo;
Ae, Takako;
Ishido, Kenji;
Nakatani, Kento;
Naruke, Akira;
Katada, Chikatoshi

Publication type:

Article

A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 415, doi. 10.1007/s00280-011-1704-y

By:

De Jesus-Acosta, Ana;
Oliver, George;
Blackford, Amanda;
Kinsman, Katharine;
Flores, Edna;
Wilfong, Lalan;
Zheng, Lei;
Donehower, Ross;
Cosgrove, David;
Laheru, Daniel;
Le, Dung;
Chung, Ki;
Diaz, Luis

Publication type:

Article

Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 477, doi. 10.1007/s00280-011-1717-6

By:

Xenidis, N.;
Chelis, L.;
Amarantidis, K.;
Chamalidou, E.;
Dimopoulos, P.;
Courcoutsakis, N.;
Tentes, A.;
Chiotis, A.;
Prassopoulos, P.;
Kakolyris, S.

Publication type:

Article

Meta-analysis of docetaxel-based doublet versus docetaxel alone as second-line treatment for advanced non-small-cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 99, doi. 10.1007/s00280-011-1678-9

By:

Qi, Wei-Xiang;
Shen, Zan;
Yao, Yang

Publication type:

Article

A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen).

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 115, doi. 10.1007/s00280-011-1680-2

By:

Reni, Michele;
Cereda, Stefano;
Rognone, Alessia;
Belli, Carmen;
Ghidini, Michele;
Longoni, Simonetta;
Fugazza, Clara;
Rezzonico, Sara;
Passoni, Paolo;
Slim, Najla;
Balzano, Giampaolo;
Nicoletti, Roberto;
Cappio, Stefano;
Doglioni, Claudio;
Villa, Eugenio

Publication type:

Article

Docetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C-erythromycin breath test and the antipyrine clearance test.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 125, doi. 10.1007/s00280-011-1676-y

By:

Michael, M.;
Cullinane, C.;
Hatzimihalis, A.;
O'Kane, C.;
Milner, A.;
Booth, R.;
Schlicht, S.;
Clarke, S.;
Francis, P.

Publication type:

Article

Tumor growth modeling from clinical trials reveals synergistic anticancer effect of the capecitabine and docetaxel combination in metastatic breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1413, doi. 10.1007/s00280-011-1628-6

By:

Frances, N.;
Claret, L.;
Bruno, R.;
Iliadis, A.

Publication type:

Article

Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II study.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1477, doi. 10.1007/s00280-011-1645-5

By:

Chang, Peter;
Tzeng, Cheng-Hwai;
Chen, Ming-Huang;
Tsao, Chao-Jung;
Su, Wu-Chou;
Hwang, Wei-Shuo;
Chang, Yi-Fang;
Chang, Shyue-Yih;
Yang, Muh-Hwa

Publication type:

Article

Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1497, doi. 10.1007/s00280-011-1642-8

By:

Sen, Fatma;
Saglam, Esra;
Toker, Alper;
Dilege, Sukru;
Kizir, Ahmet;
Oral, Ethem;
Saip, Pinar;
Sakallioglu, Barkin;
Topuz, Erkan;
Aydiner, Adnan

Publication type:

Article

Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1575, doi. 10.1007/s00280-011-1648-2

By:

Binder, Daniel;
Hübner, Ralf-Harto;
Temmesfeld-Wollbrück, Bettina;
Schlattmann, Peter

Publication type:

Article

Severe fluoropyrimidine-related toxicity: clinical implications of DPYD analysis and UH2/U ratio evaluation.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1355, doi. 10.1007/s00280-011-1709-6

By:

Giorgio, E.;
Caroti, C.;
Mattioli, F.;
Uliana, V.;
Parodi, M.;
D'Amico, Mauro;
Fucile, C.;
Marini, V.;
Forzano, F.;
Cassola, G.;
Martelli, A.;
Faravelli, F.;
Di Maria, E.

Publication type:

Article

Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1255, doi. 10.1007/s00280-011-1609-9

By:

Zamboni, William;
Combest, Austin;
DeLoia, Julie;
Edwards, Robert;
Bridges, Arlene;
Zamboni, Beth;
Walko, Christine;
Yu, Angela;
Krivak, Thomas;
Kelley, Joseph

Publication type:

Article

Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 4, p. 879, doi. 10.1007/s00280-011-1563-6

By:

Wu, Hongju;
Xin, Yan;
Zhao, Jing;
Sun, Dan;
Li, Wenhui;
Hu, Yueyun;
Wang, Shasha

Publication type:

Article

Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 4, p. 1009, doi. 10.1007/s00280-011-1570-7

By:

Murialdo, R.;
Bertolotti, F.;
Pastorino, G.;
Mencoboni, M.;
Bergaglio, M.;
Folco, U.;
Cinzia, N.;
Vaira, F.;
Simoni, C.;
Canobbio, L.;
Parodi, M.;
Brema, Fulvio;
Ballestrero, Alberto

Publication type:

Article

Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma.

Published in:

2011

By:

Eroglu, Zeynep;
Kong, Kevin;
Jakowatz, James;
Samlowski, Wolfram;
Fruehauf, John

Publication type:

Report

Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 3, p. 571, doi. 10.1007/s00280-010-1514-7

By:

Awasthi, Niranjan;
Schwarz, Margaret;
Schwarz, Roderich

Publication type:

Article

The uptake of paclitaxel and docetaxel into ex vivo porcine bladder tissue from polymeric micelle formulations.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 431, doi. 10.1007/s00280-010-1499-2

By:

Tsallas, Antonia;
Jackson, John;
Burt, Helen

Publication type:

Article

A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 415, doi. 10.1007/s00280-010-1508-5

By:

Kotsakis, Athanasios;
Agelaki, Sophia;
Vardakis, Nikolaos;
Stathopoulos, George;
Vamvakas, Lambros;
Kalykaki, Antonia;
Kentepozidis, Nikolaos;
Kontopodis, Emmanouel;
Sfakiotaki, Georgia;
Mavroudis, Dimitris;
Georgoulias, Vassilis

Publication type:

Article

Synergistic interactions between peloruside A and other microtubule-stabilizing and destabilizing agents in cultured human ovarian carcinoma cells and murine T cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 1, p. 117, doi. 10.1007/s00280-010-1461-3

By:

Wilmes, Anja;
O'Sullivan, David;
Chan, Ariane;
Chandrahasen, Clarissa;
Paterson, Ian;
Northcote, Peter;
Flamme, Anne;
Miller, John

Publication type:

Article

Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 1, p. 177, doi. 10.1007/s00280-010-1452-4

By:

Kim, Jung;
Lee, Jeeyun;
Han, Boram;
Park, Se;
Park, Joon;
Park, Young;
Lim, Ho;
Kang, Won

Publication type:

Article

Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1257, doi. 10.1007/s00280-010-1401-2

By:

Lu, Yen-Shen;
Chen, Dar-Ren;
Tseng, Ling-Min;
Yeh, Dah-Cherng;
Chen, Shou-Tung;
Hsieh, Chia-Ming;
Wang, Hwei-Chung;
Yeh, Hsien-Tang;
Kuo, Sung-Hsin;
Huang, Chiun-Sheng

Publication type:

Article

NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1353, doi. 10.1007/s00280-010-1426-6

By:

Hilli, Johanna;
Sailas, Liisa;
Jyrkkiö, Sirkku;
Pyrhönen, Seppo;
Laine, Kari

Publication type:

Article

Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1363, doi. 10.1007/s00280-010-1433-7

By:

Kunisaki, Chikara;
Takahashi, Masazumi;
Makino, Hirochika;
Oshima, Takashi;
Fujii, Shoichi;
Takagawa, Ryo;
Kimura, Jun;
Kosaka, Takashi;
Ono, Hidetaka;
Akiyama, Hirotoshi;
Kameda, Kunio;
Kito, Fumihiko;
Morita, Satoshi;
Endo, Itaru

Publication type:

Article

Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1435, doi. 10.1007/s00280-010-1444-4

By:

Kang, Yoon-Koo;
Ryu, Min-Hee;
Yoo, Changhoon;
Chang, Heung-Moon;
Yook, Jeong;
Oh, Sung;
Kim, Byung;
Kim, Tae

Publication type:

Article

Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients.

Published in:

2011

By:

Buonerba, Carlo;
Federico, Piera;
D'Aniello, Carmine;
Rescigno, Pasquale;
Cavaliere, Carla;
Puglia, Livio;
Ferro, Matteo;
Altieri, Vincenzo;
Perdonà, Sisto;
De Placido, Sabino;
Lorenzo, Giuseppe

Publication type:

Report

Erratum to: Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients.

Published in:

2011

By:

Buonerba, Carlo;
Federico, Piera;
D'Aniello, Carmine;
Rescigno, Pasquale;
Cavaliere, Carla;
Puglia, Livio;
Ferro, Matteo;
Altieri, Vincenzo;
Perdonà, Sisto;
Placido, Sabino;
Di Lorenzo, Giuseppe

Publication type:

Correction Notice

The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1471, doi. 10.1007/s00280-011-1625-9

By:

Chew, Sin-Chi;
Singh, Onkar;
Chen, Xiangai;
Ramasamy, Rathi;
Kulkarni, Tejal;
Lee, Edmund;
Tan, Eng-Huat;
Lim, Wan-Teck;
Chowbay, Balram

Publication type:

Article

Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 783, doi. 10.1007/s00280-010-1381-2

By:

Dandamudi, Uday;
Adams, Laurel;
Johnson, Brendan;
Bauman, John;
Morris, Shannon;
Murray, Sharon;
Webb, R.;
Gartner, Elaina;
Hohl, Raymond;
Lewis, Lionel

Publication type:

Article

Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 791, doi. 10.1007/s00280-010-1382-1

By:

Oki, Yasunari;
Hirose, Takashi;
Yamaoka, Toshimitsu;
Kusumoto, Sojiro;
Shirai, Takao;
Sugiyama, Tomohide;
Okuda, Kentaro;
Nakashima, Masanao;
Murata, Yasunori;
Ohmori, Tohru;
Adachi, Mitsuru

Publication type:

Article

A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 927, doi. 10.1007/s00280-010-1389-7

By:

Sridhar, Srikala;
Canil, Christina;
Chi, Kim;
Hotte, Sebastien;
Ernst, Scott;
Wang, Lisa;
Chen, Eric;
Juhasz, Agnes;
Yen, Yun;
Murray, Peter;
Zwiebel, James;
Moore, Malcolm

Publication type:

Article

A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreas.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 3, p. 511, doi. 10.1007/s00280-010-1348-3

By:

Hill, Marisa;
Li, Xiaobai;
Kim, Sharon;
Campbell, Angela;
Culler, Kristy;
Bloomston, Mark;
Zalupski, Mark;
Hejna, Gwen;
Bekaii-Saab, Tanios

Publication type:

Article